STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

MacroGenics (Nasdaq: MGNX) announced that Eric Risser, President and CEO, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025 at 7:55 am ET in Miami, FL.

A live webcast will be available via the company's Investor Relations "Events & Presentations" page and an archived replay will be maintained on the website for 30 days.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

ROCKVILLE, MD, Nov. 25, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, at 7:55 am ET in Miami, FL.

A webcast of the presentation may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain an archived replay of the webcast on its website for 30 days.

About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused on developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.     



Contacts:
Jim Karrels, Senior Vice President, CFO
1-301-251-5172
info@macrogenics.com 

Argot Partners
1-212-600-1902
macrogenics@argotpartners.com 

FAQ

When will MacroGenics (MGNX) present at the Evercore Healthcare Conference?

MacroGenics will present on December 4, 2025 at 7:55 am ET.

How can investors watch MacroGenics (MGNX) at the conference on December 4, 2025?

Investors can access a live webcast via MacroGenics' Investor Relations "Events & Presentations" page.

Will MacroGenics (MGNX) provide a replay of the Evercore conference presentation?

Yes. An archived replay will be available on the company website for 30 days after the event.

Who from MacroGenics (MGNX) will speak at the Evercore Healthcare Conference?

Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat.

Where is the 8th Annual Evercore Healthcare Conference that MacroGenics (MGNX) will attend?

The conference is in Miami, FL and MacroGenics' session is scheduled for December 4, 2025.
Macrogenics Inc

NASDAQ:MGNX

MGNX Rankings

MGNX Latest News

MGNX Latest SEC Filings

MGNX Stock Data

89.83M
57.98M
3.25%
80.43%
5.95%
Biotechnology
Pharmaceutical Preparations
Link
United States
Rockville